137 related articles for article (PubMed ID: 37865960)
41. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
42. Exosomal miR-192-5p secreted by bone marrow mesenchymal stem cells inhibits hepatic stellate cell activation and targets PPP2R3A.
Tan J; Chen M; Liu M; Chen A; Huang M; Chen X; Tian X; Chen W
J Histotechnol; 2023 Dec; 46(4):158-169. PubMed ID: 37226801
[TBL] [Abstract][Full Text] [Related]
43. PGE
Brea R; Motiño O; Francés D; García-Monzón C; Vargas J; Fernández-Velasco M; Boscá L; Casado M; Martín-Sanz P; Agra N
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):325-337. PubMed ID: 29109031
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-122-5p prevents proliferation and promotes apoptosis of hepatic stellate cells by suppressing the cellular-Abelsongene/histone deacetylases 2 pathway.
Wu Z; Wang J; Feng J; Ying L
Hum Exp Toxicol; 2022; 41():9603271221084672. PubMed ID: 35303413
[TBL] [Abstract][Full Text] [Related]
45. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
[TBL] [Abstract][Full Text] [Related]
46. Regulation of gasdermin D by miR-379-5p is involved in arsenite-induced activation of hepatic stellate cells and in fibrosis via secretion of IL-1β from human hepatic cells.
Li J; Xue J; Wang D; Dai X; Sun Q; Xiao T; Wu L; Xia H; Mostofa G; Chen X; Wei Y; Chen F; Quamruzzaman Q; Zhang A; Liu Q
Metallomics; 2019 Feb; 11(2):483-495. PubMed ID: 30643918
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
[TBL] [Abstract][Full Text] [Related]
48. miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-β.
Chen X; Zhu S; Chen SY; Wang JN; Sun LJ; Tao SM; Li XF; Li HD; Sun YY; Xu CH; Suo XG; Ji ML; Huang C; Meng XM; Li J
Int Immunopharmacol; 2022 Sep; 110():109034. PubMed ID: 35834952
[TBL] [Abstract][Full Text] [Related]
49. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway.
Wang J; Chu ES; Chen HY; Man K; Go MY; Huang XR; Lan HY; Sung JJ; Yu J
Oncotarget; 2015 Mar; 6(9):7325-38. PubMed ID: 25356754
[TBL] [Abstract][Full Text] [Related]
50. β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation.
Ge WS; Wang YJ; Wu JX; Fan JG; Chen YW; Zhu L
Mol Med Rep; 2014 Jun; 9(6):2145-51. PubMed ID: 24691643
[TBL] [Abstract][Full Text] [Related]
51. MiR-9a-5p regulates proliferation and migration of hepatic stellate cells under pressure through inhibition of Sirt1.
Qi F; Hu JF; Liu BH; Wu CQ; Yu HY; Yao DK; Zhu L
World J Gastroenterol; 2015 Sep; 21(34):9900-15. PubMed ID: 26379395
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFβ1 and lipopolysaccharide.
Zou Y; Cai Y; Lu D; Zhou Y; Yao Q; Zhang S
Cell Signal; 2017 Nov; 39():1-8. PubMed ID: 28739486
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-494-3p prevents liver fibrosis and attenuates hepatic stellate cell activation by inhibiting proliferation and inducing apoptosis through targeting TRAF3.
Li H; Zhang L; Cai N; Zhang B; Sun S
Ann Hepatol; 2021; 23():100305. PubMed ID: 33434689
[TBL] [Abstract][Full Text] [Related]
54. LncRNA FRMD6-AS1/miR-491-5p/USP13 pathway attenuated ferroptosis and contributed to liver fibrosis.
Li Z; Zou W; Jin X; Wang Y
Environ Toxicol; 2024 Jun; 39(6):3760-3771. PubMed ID: 38558500
[TBL] [Abstract][Full Text] [Related]
55. miRNA-150-5p promotes hepatic stellate cell proliferation and sensitizes hepatocyte apoptosis during liver fibrosis.
Chen W; Yan X; Yang A; Xu A; Huang T; You H
Epigenomics; 2020 Jan; 12(1):53-67. PubMed ID: 31833387
[No Abstract] [Full Text] [Related]
56. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
[TBL] [Abstract][Full Text] [Related]
57. Identification lncRNA LOC102551149/miR-23a-5p pathway in hepatic fibrosis.
Dong Z; Li S; Si L; Ma R; Bao L; Bo A
Eur J Clin Invest; 2020 Jun; 50(6):e13243. PubMed ID: 32306379
[TBL] [Abstract][Full Text] [Related]
58. The miR-23b/27b/24-1 Cluster Inhibits Hepatic Fibrosis by Inactivating Hepatic Stellate Cells.
Wan LY; Peng H; Ni YR; Jiang XP; Wang JJ; Zhang YQ; Ma L; Li R; Han L; Tan Y; Li JM; Cai WL; Yuan WF; Liang JJ; Huang L; Wu X; Zhou Q; Cheng QN; Yang X; Liu MY; Ai WB; Liu CB; Zhang H; Wu JF
Cell Mol Gastroenterol Hepatol; 2022; 13(5):1393-1412. PubMed ID: 35093591
[TBL] [Abstract][Full Text] [Related]
59. Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice.
Liu QW; Ying YM; Zhou JX; Zhang WJ; Liu ZX; Jia BB; Gu HC; Zhao CY; Guan XH; Deng KY; Xin HB
Stem Cell Res Ther; 2022 Jun; 13(1):224. PubMed ID: 35659360
[TBL] [Abstract][Full Text] [Related]
60. miR-654-5p Contributes to the Activation and Proliferation of Hepatic Stellate Cells by Targeting RXRα.
Ma H; Wang X; Liu X; Wang C; Gao X; Niu J
Front Cell Dev Biol; 2022; 10():841248. PubMed ID: 35465330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
